Search for: "Cepheid"
Cepheid Receives FDA Clearance for Xpert SA Nasal Complete, the First Molecular Test for Simultaneous Detection and Differentiation of S. aureus & MRSA Colonization
HSMN NewsFeed,
8 Jun 2010:
Diagnostics, FDA
[Cepheid, Xpert SA Nasal Complete, GeneXpert, MRSA]
|
Portola Pharmaceuticals Announces Senior Management and Board Changes
HSMN NewsFeed,
11 Mar 2010:
Biopharmaceuticals, Personnel
[Portola Pharmaceuticals]
|
Cepheid Receives FDA Clearance for First Rapid and Accurate Surveillance Test for vanA the Resistance Gene Most Associated with Hospital-Acquired VRE Infections
HSMN NewsFeed,
6 Jan 2010:
Diagnostics, FDA
[Cepheid, Xpert vanA, vancomycin-resistant enterococci, GeneXpert]
|
Cepheid Receives FDA Emergency Use Authorization (EUA) for First 2009 H1N1 Influenza Assay for CLIA 'Moderate Complexity' Laboratories
HSMN NewsFeed,
4 Jan 2010:
Diagnostics, FDA
[Cepheid, Xpert Flu A, GeneXpert, H1N1, influenza]
|
Gen-Probe to Acquire Prodesse, Leader in Molecular Testing for Respiratory Infectious Diseases, for $60 Million in Cash Plus Potential Milestone Payments
HSMN NewsFeed,
6 Oct 2009:
Diagnostics, Acquisitions
[Gen-Probe, Prodesse]
|
Cepheid Receives FDA Clearance for First On-Demand Molecular Diagnostic Test for Clostridium difficile Infection
HSMN NewsFeed,
13 Jul 2009:
Diagnostics, FDA
[Cepheid, Xpert C. difficile, Clostridium]
|
Cepheid Announces European Release of First On-Demand Molecular Pre-Surgical Screening Test for Simultaneous Detection of Methicillin-Sensitive and Resistant S. aureus
HSMN NewsFeed,
31 Mar 2009:
Diagnostics
[Cepheid, Xpert MRSA/SA, MRSA, GeneXpert]
|
Cepheid Launches First On-Demand Molecular Diagnostic Test for Clostridium Difficile Into European Market
HSMN NewsFeed,
10 Nov 2008:
Diagnostics
[Cepheid, Xpert C. difficile, GeneXpert System]
|
Cepheid Accelerates Direct Sales Channel in UK With Pending Acquisition of Medical Distributor Stretton Scientific
HSMN NewsFeed,
3 Nov 2008:
Diagnostics, Mergers & Acquisitions
[Cepheid, Stretton Scientific]
|
Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures
HSMN NewsFeed,
1 Oct 2008:
Diagnostics, FDA
[Cepheid, Xpert MRSA/SA BC test, MRSA]
|
Cepheid Receives FDA Clearance for First Rapid On-Demand Molecular Diagnostic Test for MRSA and S. aureus
HSMN NewsFeed,
29 Sep 2008:
Diagnostics, FDA
[Cepheid, Xpert MRSA/SA, GeneXpert, MRSA]
|
Cepheid Signs Group Purchasing Contract With Premier Healthcare Alliance, One of the Largest U.S. Group Purchasing Organizations
HSMN NewsFeed,
12 May 2008:
Diagnostics, Group Purchasing
[Cepheid, Premier Purchasing, GeneXpert, Xpert MRSA]
|
ParagonDx Receives FDA 510(k) Marketing Clearance for Warfarin Sensitivity Genotyping Kit
HSMN NewsFeed,
5 May 2008:
Diagnostics, FDA
[ParagonDx, warfarin sensitivity, Warfarin, Coumadin, CYP2C9, VKORC1]
|
Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market
HSMN NewsFeed,
25 Feb 2008:
Diagnostics
[Cepheid, Instrumentation Laboratory, Xpert HemosIL, GeneXpert]
|
Cepheid Appoints Senior VP, Chief Financial Officer to Management Team
HSMN NewsFeed,
11 Feb 2008:
Diagnostics, Personnel
[Cepheid]
|
Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
HSMN NewsFeed,
29 Jan 2008:
Diagnostics, Regulatory
[Cepheid, GeneXpert, MRSA]
|
Cepheid Begins Shipment of Next Generation GeneXpert(R) Molecular Diagnostic Systems
HSMN NewsFeed,
7 Jan 2008:
Diagnostics
[Cepheid, GeneXpert]
|
Cepheid Launches New GeneXpert(R) Tests in Europe for Simultaneous, Rapid Detection of Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus
HSMN NewsFeed,
4 Dec 2007:
Diagnostics
[Cepheid, GeneXpert, MRSA]
|
Cepheid and Broadlane Sign Group Purchasing Contract for GeneXpert(R) Systems and Xpert(TM) Molecular Diagnostic Tests, Including Xpert MRSA
HSMN NewsFeed,
29 Nov 2007:
Diagnostics, Group Purchasing
[Cepheid, Broadlane, GeneXpert]
|
Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
HSMN NewsFeed,
24 Sep 2007:
Diagnostics, Licensing
[Cepheid]
|
Cepheid's Xpert(TM) MRSA Test for Methicillin-Resistant Staphylococcus Aureus Receives FDA Clearance
HSMN NewsFeed,
18 Apr 2007:
Diagnostics, FDA
[Cepheid, Xpert MRSA test, GeneXpert]
|
Cepheid's Xpert(TM) EV Test for Enteroviral Meningitis Gains Adoption at Approximately 20 Leading U.S. Medical Centers
HSMN NewsFeed,
11 Apr 2007:
Diagnostics
[Cepheid, Enterovirus Testing, Xpert EV, GeneXpert]
|
Cepheid Introduces CE Mark Certified Smart HBV(TM) Test for SmartCycler(R) System
HSMN NewsFeed,
22 Mar 2007:
Diagnostics, Regulatory
[Cepheid, Hepatitis B, Smart HBV, SmartCycler]
|
Cepheid's Xpert(TM) EV Test for Enteroviral Meningitis, Run on the GeneXpert Platform, Receives FDA Clearance
HSMN NewsFeed,
19 Mar 2007:
Diagnostics, FDA
[Cepheid, Xpert EV test, GeneXpert, meningitis]
|
Cepheid Acquires Sangtec Molecular Diagnostics AB
HSMN NewsFeed,
15 Feb 2007:
Diagnostics, Mergers & Acquisitions
[Cepheid, Sangtec Molecular Diagnostics]
|
Cepheid and bioMerieux Enter Into Strategic Agreements to Develop and Market Sepsis and MRSA Products
HSMN NewsFeed,
17 Jan 2007:
Diagnostics
[Cepheid, bioMerieux, sepsis assay]
|
Urigen N.A., Inc. Appoints Dennis Giesing, PhD As Director of Product Development
HSMN NewsFeed,
8 Jan 2007:
Biopharmaceuticals, Urology, Personnel
[Urigen N.A.]
|
Cepheid Extends European Product Line With Launch of Xpert(TM) MRSA Test for GeneXpert(R) System
HSMN NewsFeed,
26 Oct 2006:
Diagnostics
[Cepheid, Xpert MRSA, GeneXpert, MRSA]
|
Cepheid Submits Xpert(TM) EV Test for United States Regulatory Approval
HSMN NewsFeed,
17 Apr 2006:
Diagnostics
[Cepheid, Xpert EV Assay, Enterovirus, GeneXpert]
|
Cepheid Initiates CE IVD Products in Europe With Launch of GeneXpert(R) System and Xpert BCR-ABL Monitor(TM) Assay
HSMN NewsFeed,
23 Feb 2006:
Diagnostics, Oncology
[Cepheid, GeneXpert]
|
|
|
Public
Feeds 
Full text >>
